AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
EZETIMIBE 10.000 Mg ; SIMVASTATIN 20.000 Mg ;
11 registrations across 1 African market— 11 active
Markets with EZETIMIBE 10.000 Mg ; SIMVASTATIN 20.000 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SIMVASTIMIBE 10/20 mg Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Vastatinal 20/10 mg Tablets | 🇪🇬Egypt | universal pharmaceutical industries (unipharma) | active | — |
| Givarorck 10/20 mg Tablets | 🇪🇬Egypt | Chemedica | active | — |
| Ezegrand Film Coated Tablets | 🇪🇬Egypt | Delta grand pharma for pharmaceutical industries - DGP | active | — |
| Vastatinal 20/10 mg Tablets | 🇪🇬Egypt | universal pharmaceutical industries (unipharma) | active | — |
| VETOSIMVAMEB 10/20 mg Tablets | 🇪🇬Egypt | vetopharm nerhado international for pharmaceuticals and chemicals | active | — |
| Givarorck 10/20 mg Tablets | 🇪🇬Egypt | Chemedica | active | — |
| SIMVASTIMIBE 10/20 mg Tablets | 🇪🇬Egypt | Eva pharma for Pharmaceuticals and Medical Appliances - Eva Pharma | active | — |
| Ezegrand Film Coated Tablets | 🇪🇬Egypt | Delta grand pharma for pharmaceutical industries - DGP | active | — |
| Timbestatin 10/20 mg Film Coated Tablets | 🇪🇬Egypt | Viida Pharma | active | — |
| VETOSIMVAMEB 10/20 mg Tablets | 🇪🇬Egypt | vetopharm nerhado international for pharmaceuticals and chemicals | active | — |
EZETIMIBE 10.000 Mg ; SIMVASTATIN 20.000 Mg ; in Africa — Regulatory Overview
EZETIMIBE 10.000 Mg ; SIMVASTATIN 20.000 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.